Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomized trial showed.

Prostate cancer survivorship research focuses largely on oncological outcome; however, fewer studies are available that assess the effects of prostate cancer and its treatment on bladder function.

CLEVELAND, Ohio — The Cleveland Clinic said it recently became the first hospital to use a new wireless, catheter-free device for monitoring bladder function called the Glean Urodynamics System. This ...

A wireless device called the UroMonitor enables accurate, noninvasive monitoring of bladder pressure in patients with overactive bladder, reports a pilot study in the July issue of The Journal of ...

A comprehensive approach to the evaluation of women with suspected BOO is advised, in order to arrive at the correct diagnosis and to select appropriate treatment options. No single test can clinch ...

Overactive bladder (OAB) is prevalent among women with fibromyalgia (FM) and is associated with higher symptom severity and comorbidity, according to a study published in Neurourology Urodynamics.

Stony Brook performs first East Coast use of Glean Urodynamics. Wireless, catheter-free system monitors bladder in real time. Technology is designed to improve patient comfort and diagnostic precision ...

Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment. Led by ...